Digital Telepathology Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Global Digital Telepathology Market Overview
According to SPER Market Research, the Global Digital Telepathology Market is estimated to reach USD 2.19 billion by 2032 with a CAGR of 9.6%. Digital telepathology, which can be used for remote primary diagnoses, quality control, second opinion consultations, research, and educational reasons, is the practice of remote pathology employing telecommunication links to permit the electronic transfer of digital pathology pictures. By enabling quick connections with experts, digital telepathology helps an increasing number of laboratories around the world provide pathology services.
Impact of COVID-19 on the Global Digital Telepathology MarketYears ago, digital pathology was created to enable pathologists to remotely work together on cases and increase the precision of diagnostic procedures by exchanging digital pictures among laboratories. Due to the US Food and Drug Administration's (FDA) and the Centers for Medicare & Medicaid Services' (CMS) stringent federal restrictions, the US fell behind the majority of developed nations in terms of adopting digital pathology prior to the COVID-19 pandemic.
Scope of the Report:Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032
Segments covered By Type, By Application, By End User
Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
Companies Covered GE Healthcare, Glencoe Software, Inspirata, Kanteron Systems, Leica Biosystems, MikroSkan Technologies Inc., Olympus Corporation, OptraSCAN,
Global Digital Telepathology Market Segmentation:By Application: Based on the Application, Global Digital Telepathology Market is segmented as; Diagnosis, Education, Research, Others.
By End User: Based on the End User, Global Digital Telepathology Market is segmented as; Academic Institutes, Diagnostic Centers and Pathology Clinics, Hospital, Pharmaceutical and Biotech Companies, Research Organizations, Others.
By Region: The largest market is in North America, where moderate growth is anticipated over the following ten years. This is brought on by a robust healthcare system, laws like the Affordable Care Act, a high incidence of different cancers, and an aging population that need medical attention.